{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:55:00Z","timestamp":1793876100025,"version":"4.7.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To report the incidence, risk factors, clinical course, and visual outcomes of rhegmatogenous retinal detachment (RRD) and vitreous hemorrhage (VH) after cryotherapy for retinoblastoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A single-center retrospective review of patients treated with cryotherapy for retinoblastoma between January 2013 and December 2022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 124 eyes in 92 patients treated with cryotherapy, RRD developed in 7 (6%) and VH in 9 (7%) eyes. RRD persisted in one eye (&lt;1%) and VH in five eyes (4%), while RRD and VH resolved spontaneously in remaining eyes. Increased cryotherapy applications were associated with VH risk (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01) but not with RRD. Cryotherapy recipients who had also received intraarterial chemotherapy (n = 50) were associated with VH risk (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01). Management for persistent complications were referral for scleral buckling (1 RRD), observation (1 VH), or enucleation (4 VH: three tumor progression and one no retinal view). Cryotherapy-induced visual loss occurred in one RRD (&lt;1%, baseline vs. final visual acuity: 20\/20 vs. 20\/40) and in one VH (&lt;1%, enucleation due to no view). Baseline vision was preserved in most of the globe-salvaged cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Complications post-cryotherapy in retinoblastoma management were rare. Increased cryotherapy applications may increase the risk of VH, but cryotherapy-related visual loss was rare.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004495","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T17:00:34Z","timestamp":1745600434000},"page":"1591-1598","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["OUTCOMES OF CRYOTHERAPY FOR THE TREATMENT OF RETINOBLASTOMA IN 92 CONSECUTIVE PATIENTS"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-9580","authenticated-orcid":false,"given":"Younghoon","family":"Kim","sequence":"first","affiliation":[{"name":"Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy S.","family":"Negretti","sequence":"additional","affiliation":[{"name":"Judith Kingston Retinoblastoma Unit, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom;"},{"name":"Department of Ophthalmology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom;"},{"name":"Ocular Oncology Service, Moorfields Eye Hospital, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Westcott","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep S.","family":"Sagoo","sequence":"additional","affiliation":[{"name":"Judith Kingston Retinoblastoma Unit, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom;"},{"name":"Department of Ophthalmology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom;"},{"name":"Ocular Oncology Service, Moorfields Eye Hospital, London, United Kingdom; and"},{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6624-1518","authenticated-orcid":false,"given":"M. Ashwin","family":"Reddy","sequence":"additional","affiliation":[{"name":"Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom;"},{"name":"Judith Kingston Retinoblastoma Unit, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom;"},{"name":"Department of Ophthalmology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Part 1","key":"R1-20250723","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-9394(67)90234-6","article-title":"The cryosurgical treatment of intraocular tumors","volume":"63","author":"Lincoff","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"R2-20250723","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.4103\/ijo.IJO_721_20","article-title":"Modern treatment of retinoblastoma: a 2020 review","volume":"68","author":"Ancona-Lezama","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R3-20250723","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0002-9394(89)90116-5","article-title":"The role of cryotherapy in the management of retinoblastoma","volume":"108","author":"Shields","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"R4-20250723","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/S0161-6420(98)91139-3","article-title":"Surgical repair of rhegmatogenous retinal detachment after treatment for retinoblastoma","volume":"105","author":"Baumal","year":"1998","journal-title":"Ophthalmology"},{"key":"R5-20250723","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00006982-200001000-00004","article-title":"Presumed rhegmatogenous retinal detachment in patients with retinoblastoma","volume":"20","author":"Lim","year":"2000","journal-title":"Retina"},{"key":"R6-20250723","doi-asserted-by":"crossref","first-page":"1486757","DOI":"10.1155\/2020\/1486757","article-title":"Persistent retinal detachment in retinoblastoma: the challenges","volume":"2020","author":"El Hamichi","year":"2020","journal-title":"J Ophthalmol"},{"key":"R7-20250723","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(00)00407-4","article-title":"Rhegmatogenous retinal detachment in retinoblastoma patients undergoing chemoreduction and cryotherapy","volume":"129","author":"Anagnoste","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R8-20250723","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/01.iae.0000225350.83931.f6","article-title":"Vitreoretinal complications of retinoblastoma treatment","volume":"26","author":"Tawansy","year":"2006","journal-title":"Retina"},{"key":"R9-20250723","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/IAE.0000000000001382","article-title":"Rhegmatogenous retinal detachment after intraarterial chemotherapy for retinoblastoma: the 2016 Founders Award Lecture","volume":"37","author":"Shields","year":"2017","journal-title":"Retina"},{"key":"R10-20250723","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archopht.119.11.1613","article-title":"Intraocular surgery after treatment of retinoblastoma","volume":"119","author":"Honavar","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R11-20250723","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Linn Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"R12-20250723","first-page":"125","article-title":"Biological effects of freezing and supercooling","volume":"35","author":"Smith","year":"1961","journal-title":"Yale J Biol Med"},{"key":"R13-20250723","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.3390\/jcm9124037","article-title":"Predictive risk factors for retinal redetachment following uncomplicated pars plana vitrectomy for primary rhegmatogenous retinal detachment","volume":"9","author":"Guber","year":"2020","journal-title":"J Clin Med"},{"key":"R24-20250723","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4103\/ijo.IJO_866_19","article-title":"Intra-arterial chemotherapy in retinoblastoma - a paradigm change","volume":"67","author":"Manjandavida","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"R14-20250723","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ophtha.2006.05.080","article-title":"Spontaneous reattachment of rhegmatogenous retinal detachment","volume":"114","author":"Cho","year":"2007","journal-title":"Ophthalmology"},{"key":"R15-20250723","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(01)00652-2","article-title":"Subclinical retinal detachment resulting from asymptomatic retinal breaks: prognosis for progression and regression","volume":"108","author":"Byer","year":"2001","journal-title":"Ophthalmology"},{"key":"R16-20250723","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3341\/kjo.2012.26.2.135","article-title":"A developmental mechanism of spontaneous reattachment in rhegmatogenous retinal detachment","volume":"26","author":"Chung","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"R18-20250723","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000508721","article-title":"Segmental scleral buckle surgical technique for repair of a rhegmatogenous retinal detachment in retinoblastoma: a case and review of the literature","volume":"7","author":"Wendt","year":"2021","journal-title":"Ocul Oncol Pathol"},{"key":"R22-20250723","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archopht.117.7.885","article-title":"Thermotherapy for retinoblastoma","volume":"117","author":"Shields","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R23-20250723","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mpa.2000.107902","article-title":"Focal therapy in the management of retinoblastoma: when to start and when to stop","volume":"4","author":"Hamel","year":"2000","journal-title":"J AAPOS"},{"key":"R25-20250723","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.ophtha.2021.01.024","article-title":"Incidence of retinoblastoma has increased: results from 40 European countries","volume":"128","author":"Stacey","year":"2021","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T02:00:26Z","timestamp":1753236026000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004495","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}